Contact Us
1 min read

DIA 2019: Watch the Wrap-up of UBC’s Participation

Continue the conversation on optimizing evidence generation and patient safety.
See more of the developments UBC's evidence development and safety & risk management teams discussed.

UBC was pleased to connect with so many industry colleagues at DIA 2019. We look forward to continuing the conversation on important clinical development and safety developments.

Other Recent Posts

View More
The acquisition strengthens UBC’s leadership in evidence generation offerings with globally recognized expertise in HEOR, medical affairs and market access.
Press
January 6, 20264 min read

UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities

United BioSource LLC (UBC) has acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical and economic analysis.
nanotechnology and abstract graphene structures
Press
November 20, 20256 min read

Datavant and UBC Partner to Transform Observational Research and Patient Access for Biopharmaceutical Sponsors

Datavant and United BioSource Corporation (UBC) have joined forces to transform late-phase research and patient access programs for biopharmaceutical sponsors. By combining Datavant’s privacy-first data connectivity with UBC’s expertise in specialty therapies, the partnership introduces two new offerings: Modern Observational Research Study Designs and Enhanced Patient Access Programs. These solutions aim to accelerate evidence generation, improve patient outcomes, and set a new standard for real-world research and access.
Above view of group of business persons in business meeting. Group of entrepreneurs on meeting in board room. Corporate business team on meeting in the office.
Press
August 11, 20254 min read

UBC Launches New Pharmacovigilance Reporting Capabilities

UBC launches new RxLogix pharmacovigilance reporting platform to enhance drug safety capabilities with advanced aggregate reporting, real-time analytics, and reduced regulatory risk for biopharmaceutical companies.
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.